The Jynneos vaccine from Bavarian Nordic A/S (OMX:BAVA), the most widely used vaccine to protect against monkeypox, tends to have generally mild side effects according to clinical trial data. It is also clear that the Jynneos vaccine can help reduce the severity of monkeypox infections. Researchers are uncertain, however, about how the vaccine’s potential to…
U.S. to boost supplies of Tpoxx to fight monkeypox outbreak
The Administration for Strategic Preparedness and Response (ASPR) will make 50,000 courses of the small-molecule drug Tpoxx (tecovirimat) from SIGA Technologies (Nasdaq: SIGA) available to help fight the monkeypox outbreak. There have been 13,517 confirmed monkeypox/orthopoxvirus cases in the U.S. to date, according to the CDC. In 2018, Tpoxx became the first drug to win an…
Jynneos vaccine: The best weapon against monkeypox?
Over the past few months, healthcare leaders have been working on identifying vaccines to prevent the spread of monkeypox. One such development is the use of Bavarian Nordic’s (OMX:BAVA) Jynneos vaccine for the prevention and treatment of the fast-spreading disease. The Jynneos vaccine won approval in the U.S. in 2019 for the prevention of monkeypox…
3 critical monkeypox vaccine questions
In the U.S., federal authorities have allowed two vaccines to be used to reduce the risk of monkeypox virus infection. The preferred option is the Jynneos vaccine from Bavarian Nordic (OMX:BAVA), followed by Emergent BioSolutions’ (NYSE:EBS) ACAM2000. While vaccination efforts are ramping up, California, New York and Illinois have declared states of emergency as the…
U.S. secures option to purchase millions of monkeypox vaccine doses from Bavarian Nordic
As monkeypox cases are investigated in North America and Europe, Bavarian Nordic A/S (OMX:BAVA) has secured a contract worth potentially $119 million with Biomedical Advanced Research and Development Authority (BARDA) to convert bulk vaccine into freeze-dried doses of Jynneos vaccine. Jynneos was FDA approved for both smallpox and monkeypox in 2019. Smallpox and monkeypox are broadly…